AU2002212471A1 - Peptides for use in the treatment of alzheimer's disease - Google Patents

Peptides for use in the treatment of alzheimer's disease

Info

Publication number
AU2002212471A1
AU2002212471A1 AU2002212471A AU1247102A AU2002212471A1 AU 2002212471 A1 AU2002212471 A1 AU 2002212471A1 AU 2002212471 A AU2002212471 A AU 2002212471A AU 1247102 A AU1247102 A AU 1247102A AU 2002212471 A1 AU2002212471 A1 AU 2002212471A1
Authority
AU
Australia
Prior art keywords
alzheimer
peptides
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212471A
Inventor
Nathaniel Gavin Nicolas Milton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSIGHT BIOTECHNOLOGY Ltd
Original Assignee
INSIGHT BIOTECHNOLOGY Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026738A external-priority patent/GB0026738D0/en
Priority claimed from GB0026739A external-priority patent/GB0026739D0/en
Application filed by INSIGHT BIOTECHNOLOGY Ltd filed Critical INSIGHT BIOTECHNOLOGY Ltd
Publication of AU2002212471A1 publication Critical patent/AU2002212471A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AU2002212471A 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease Abandoned AU2002212471A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0026738A GB0026738D0 (en) 2000-11-01 2000-11-01 Diagnosis and therapeutic targeting of alzheimers disease in humans
GB0026739A GB0026739D0 (en) 2000-11-01 2000-11-01 Peptides for use in detection and therapeutic targeting of alzheimers disease
GB0026739.3 2000-11-01
GB0026738.5 2000-11-01
PCT/GB2001/004843 WO2002036614A2 (en) 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
AU2002212471A1 true AU2002212471A1 (en) 2002-05-15

Family

ID=26245223

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212471A Abandoned AU2002212471A1 (en) 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease

Country Status (4)

Country Link
US (1) US20040072753A1 (en)
EP (2) EP1538163A3 (en)
AU (1) AU2002212471A1 (en)
WO (1) WO2002036614A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749968B2 (en) * 2002-08-05 2010-07-06 The Johns Hopkins University Peptides for targeting the prostate specific membrane antigen
EP1585520A1 (en) * 2002-12-24 2005-10-19 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
JP4888876B2 (en) * 2003-06-13 2012-02-29 田平 武 Recombinant adeno-associated virus vector for the treatment of Alzheimer's disease
WO2005063796A1 (en) * 2003-12-31 2005-07-14 Posco Inhibitors of amyloid precursor protein processing
US7341991B2 (en) 2003-12-31 2008-03-11 Posco Inhibitors of amyloid precursor protein processing
RS53270B2 (en) 2005-11-30 2018-05-31 Abbvie Deutschland Monoclonal antibodies against amyloid beta protein and uses thereof
JP5475994B2 (en) 2005-11-30 2014-04-16 アッヴィ・インコーポレイテッド Anti-Aβ globulomer antibody, antigen-binding portion thereof, corresponding hybridoma, nucleic acid, vector, host cell, method for producing said antibody, composition comprising said antibody, use of said antibody and method of using said antibody.
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2124952A2 (en) 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
WO2010010469A2 (en) * 2008-07-25 2010-01-28 Abbott Gmbh & Co. Kg Abeta (x-38..43) oligomers, and processes, compositions, and uses thereof
AU2015200751B2 (en) * 2010-03-19 2016-11-10 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
GB201004575D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
GB201004551D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
JP6147665B2 (en) 2010-08-14 2017-06-14 アッヴィ・インコーポレイテッド Amyloid beta-binding protein
CN113061161B (en) * 2021-04-02 2023-09-12 河南省农业科学院动物免疫学重点实验室 Inhibitory peptide ligand of targeting amyoid-beta structure and application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385915A (en) * 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
AU3249793A (en) * 1991-12-24 1993-07-28 Isis Pharmaceuticals, Inc. Compositions and methods for modulating beta -amyloid
US5851787A (en) * 1992-04-20 1998-12-22 The General Hospital Corporation Nucleic acid encoding amyloid precursor-like protein and uses thereof
US5766846A (en) * 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
AU6955294A (en) * 1992-12-31 1994-08-15 Johanna E. Bergmann Agents for the prevention and treatment of parkinson's disease
WO1994017197A1 (en) * 1993-01-25 1994-08-04 Takeda Chemical Industries, Ltd. ANTIBODY AGAINST β-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
ES2175083T3 (en) * 1995-03-14 2002-11-16 Praecis Pharm Inc AMULOID AGGREGATION MODULATORS.
US6268479B1 (en) * 1997-03-12 2001-07-31 The Trustees Of Columbia University In The City Of New York Intracellular amyloid-beta peptide binding (ERAB) polypeptide
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US5891719A (en) * 1997-11-16 1999-04-06 Tularik Inc. IKAP nucleic acids

Also Published As

Publication number Publication date
WO2002036614A3 (en) 2003-10-02
WO2002036614A2 (en) 2002-05-10
US20040072753A1 (en) 2004-04-15
EP1538163A2 (en) 2005-06-08
EP1363939A2 (en) 2003-11-26
EP1538163A3 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
EP1392287B8 (en) Use of substituted azetidinone derivatives in the treatment of Alzheimer's disease
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU2001278084A1 (en) Model for alzheimer's disease and other neurodegenerative diseases
AU2001273132A1 (en) Compounds to treat alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
EP1007048A4 (en) Identification of agents for use in the treatment of alzheimer's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2002222156A1 (en) Human protein differentially expressed in alzheimer's disease's brain
IL172213A0 (en) Compounds useful in the therapy of alzheimer's disease and formulations containing them
AU1405899A (en) Treatment for alzheimer's disease
GB0011410D0 (en) Therapeutic combination for treating Alzheimer's disease
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
GB0011408D0 (en) Therapeutic combination for treating Alzheimer's Disease
AU2002357232A1 (en) Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
AU2003286530A1 (en) Substituted peptides useful in the treatment of alzheimer's disease
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU2001267826A1 (en) Remedies for alzheimer's disease
AU2001246518A1 (en) A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease
AU2002348687A1 (en) Macrocycles useful in the treatment of alzheimer's disease
AU2002315098A1 (en) Macrocycles useful in the treatment of alzheimer's disease